RecruitingPhase 2NCT06635629
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Studying ACTH-dependent Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Lynnette K Nieman, M.D., M.DNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Intervention
- Desmopressin(drug)
- Enrollment
- 140 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2024 – 2029
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06635629 on ClinicalTrials.govOther trials for ACTH-dependent Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT05804669A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromeCrinetics Pharmaceuticals Inc.
- RECRUITINGNCT06962202Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CTPost Graduate Institute of Medical Education and Research, Chandigarh